Assessment of tumour response to chemotherapy for metastatic colorectal cancer: Accuracy of the RECIST criteria

British Journal of Radiology

Volumn 75, Issue 899, 2002, Pages 903-908

  Trillet Lenoir, V ^a,b   Freyer, G ^a,b   Kaemmerlen, P ^c   Fond, A ^d   Pellet, O ^a   Lombard Bohas, C ^e   Gaudin, J L ^f   Lledo, G ^d   Mackiewicz, R ^g   Gouttebel, M C ^h   Moindrot, H ⁱ   Boyer, J D ^j   Chassignol, L ^k   Stremsdoefer, N ^l   Desseigne, F ^c   Moreau, J M ^m   Hedelius, F ^p   Moraillon, A ^g   Chapuis, F ⁿ   Bleuse, J P ^o   Barbier, Y ^a   Heilmann, M O ^a   Valette, P J ^e   more..

^a CENTRE HOSPITALIER LYON SUD   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CENTRE LÉON BÉRARD   (France)

^d Clinique Saint Jean   (France)

^e EDOUARD HERRIOT HOSPITAL   (France)

^f CROIX ROUSSE HOSPITAL   (France)

^g CLINIQUE PASTEUR   (France)

^h CENTRE HOSPITALIER DE ROANNE   (France)

ⁱ CENTRE HOSPITALIER DE VALENCE   (France)

^j HÔPITAL DU BOCAGE   (France)

^k Centre Hospitalier de Privas   (France)

^l Centre Hospitalier de Bourgoin   (France)

^m Centre Hospitalier de Villefranche   (France)

ⁿ HOSPICES CIVILS DE LYON   (France)

^o SANOFI   (France)

^p NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; RALTITREXED;

AGED; ANALYTIC METHOD; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL TRIAL; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MONOTHERAPY; MULTICENTER STUDY; PRACTICE GUIDELINE; PROSPECTIVE STUDY; QUANTITATIVE ASSAY; STANDARDIZATION; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR VOLUME; VALIDATION PROCESS; WORLD HEALTH ORGANIZATION;

EID: 0036861177     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.75.899.750903     Document Type: Article

References (16)

1. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981; 47: 207-14.
2. Warr D, McKinney S, Tannock I. Influence of measurement error on assessment of response to anticancer therapy: Proposal for new criteria of tumor response. J Clin Oncol 1984;2:1040-6.
3. Thiesse P, Ollivier L, Di Stefano-Louineau D, et al. Response rate accuracy in oncology trials: Reasons for interobserver variability. Groupe Français d'Immunothérapie of the Fédération Nationale des Centres de lutte contre le Cancer. J Clin Oncol 1997;15:3507-14.
4. Jonker DJ, Maroun JA, Kocha W. Survival benefit of chemotherapy in metastatic colorectal cancer: A meta-analysis of randomized controlled trials. Br J Cancer 2000;82:1789-94.
5. Chezmar JL, Rumancik WM, Megibow AJ, et al. Liver and abdominal screening in patients with cancer: CT versus MRI imaging. Radiology 1988;168:43-7.
6. James K, Eisenhauer E, Terenziani M, et al. Measuring response in solid tumors: Unidimensionnal versus bidimensional measurement. J Natl Cancer Inst 1999;91:523-8.
7. Therasse P, Arbuck SG, Eisenhauer E, et al. New guidelines to evaluate the response to treatment in solid tumours. J Natl Cancer Inst 2000;92:205-16.
8. De Gramont A, Bosset JF, Milan C, et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: A French intergroup study. J Clin Oncol 1997;15:808-15.
9. De Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 1997;18:2938-47.
10. Douillard JY, Cunningham D, Roth AD, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial. Lancet 2000;355:1041-7.
11. Cunningham D. Mature results from three large controlled studies with raltitrexed ('Tomudex'). Br J Cancer 1998;77:15-21.
12. Armitage P, Blendis LM, Smyllie HC. The measurement of observer disagreement in the recording of signs. J R Stat Soc 1966;129:98-109.
13. Buyse M, Thirion P, Carlson RW, et al. Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: A meta-analysis. Meta-analysis group in cancer. Lancet 2000;356:373-8.
14. Hilsenbeck SG, Von Hoff DD. Measuring once or twice. Does it really matter? J Natl Cancer Inst 1999;91:494-5.
15. Advanced colorectal Cancer Meta-analysis project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate. J Clin Oncol 1992;10:896-903.
16. Matzkin H, Perito PE, Solowat MS. Prognostic factors in metastatic prostate cancer. Cancer 1993;12:3788-92.